Concepedia
Statistics
Publications
9
Citations
425
H-Index
Active since
2000
Affiliations
Bayer (Germany)(Current)
Dana-Farber Cancer Institute
Broad Institute
Witten/Herdecke University
Nuvisan (Germany)
Elisabeth Pook is an author at Bayer (Germany) specializing in pharmacology, medicine, and gene expression.
Publications per year
2000–2022
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Jérôme Fagart, Alexander Hillisch, J. Huyet et al. · Journal of Biological Chemistry · 2010 · 186 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Chimeric protein probes for C5a receptors through fusion of the anaphylatoxin C5a core region with a small-molecule antagonist
Chao Zuo, Weiwei Shi, Xiaoxu Chen et al. · Science China Chemistry · 2019 · 82 citations
Medicine, Immunology, Pharmacology +14
The p65 domain from NF-κB is an efficient human activator in the tetracycline-regulatable gene expression system
Stefanie Urlinger, Vera Helbl, Jürgen Guthmann et al. · Gene · 2000 · 43 citations
Life Sciences, Molecular Biology, Molecular Genetics +9
Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription
Chunyan Luo, Elisabeth Pook, Bo Tang et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2017 · 34 citations · Full text
Life Sciences, Endocrinology, Molecular Biology +14
Cardiac output improvement by pecavaptan: a novel dual‐acting vasopressin <scp>V1a/V2</scp> receptor antagonist in experimental heart failure
Thomas Mondritzki, Thuy Anh, Julia Vogel et al. · European Journal of Heart Failure · 2020 · 23 citations · Full text
Medicine, Cardiology, Pharmacology +17
1–5 of 9